Marketing Authorization

Related by string. Marketing Authorizations * marketing : MARKET WIRE via COMTEX / authorizations : share repurchase authorization * submitted Marketing Authorization . Marketing Authorization Application MAA . Marketing Authorization Application . Market Authorization Application . Marketing Authorization Applications . European Marketing Authorizations *

Related by context. All words. (Click for frequent words.) 81 Marketing Authorisation 76 Mutual Recognition Procedure 73 Marketing Authorisation Application 73 OMP designation 72 Positive Opinion 72 Receives Marketing Authorization 71 orphan designation 70 Orphan Designation 70 Orphan Status 70 Orphan Drug status 70 FIRAZYR 70 Marketing Authorization Application MAA 70 Tostrex 69 Marketing Authorization Application 69 Orphan Drug designation 69 Receives Positive Opinion 69 Decentralized Procedure 69 Fast Track Status 69 CHMP recommendation 69 Orphan Drug Status 69 SEBIVO 68 Trobalt 68 Orphan Medicinal Product 68 orphan medicinal product 67 Raptiva R 67 Orphan Drug Designation 67 Cellegesic 67 CONBRIZA 67 Preotact R 66 Centralized Procedure 66 Marketing Authorization Applications 66 TEMODAL 66 Plenaxis R 66 Orphan designation 66 Xyrem ® 66 Retacrit 66 SYCREST 66 Scientific Advice 66 Increlex R 66 Expanded Indication 65 Application MAA 65 Adenuric R 65 Loramyc R 65 Angiox 65 Lambert Eaton Myasthenic 65 Preotact 65 Expedited Review 65 Medicinal Products EMEA 65 GTC recombinant form 64 REBETOL combination therapy 64 histamine dihydrochloride 64 Accelerated Approval 64 Marketing Authorisation Application MAA 64 Certican 64 Ceftobiprole 64 Icatibant 64 Oracea ® 64 Alvesco R 64 Product Designation 64 Product Characteristics 64 FDA Accepts 64 Thalidomide Pharmion 64 Esbriet ® 64 Civacir 64 CHMP opinion 64 Ruconest 64 Biologic License Application 64 Evoltra 64 Orphan Drug designations 64 MEZAVANT 64 Advagraf 64 RELISTOR ® 63 eprodisate KIACTA TM 63 CE Marked 63 Firdapse 63 Loramyc ® 63 Somatuline R Autogel R 63 ANDA Filing 63 Brilique 63 ULTRASE 63 XAGRID 63 XIAPEX 63 European Medicines Evaluation 63 Decentralized Procedure DCP 63 Orapred ODT 63 FDA Approvable Letter 63 granted orphan medicinal 63 Tracleer ® bosentan 63 Romiplostim 63 Rectogesic 63 Firazyr 63 PDUFA Date 63 Adenuric ® 63 CryoSeal FS System 63 DORIBAX 63 Marketing Authorizations 63 ZEFTERA TM 63 Raptiva ® 63 XIAPEX ® 63 Granted Orphan Drug 63 Increlex TM 63 FDA Orphan Drug 63 Biologic License Application BLA 63 Alvesco ® 63 Esbriet pirfenidone 63 Abstral ® 63 THELIN 63 Ciclesonide 62 Emezine 62 Bendamustine 62 Gleevec Glivec 62 Patent Covering 62 rilonacept 62 ADDERALL XR R 62 Approvable 62 Mimpara 62 tolperisone 62 Zebinix R 62 Receives Orphan Drug Designation 62 liver resection surgeries 62 Glatiramer Acetate 62 Rhucin ® 62 ONGLYZA ™ 62 Fast Track Designation 62 CE Marking 62 Pivotal Phase III 62 Revolade 62 Angiox ® 62 Receives Orphan Drug 62 Vasovist 62 Ranolazine 62 Psoriasis Drug 62 Patent Broadly Covering 62 Evoltra TM 62 SNT MC# 62 NDA Submission 62 ATryn ® GTC recombinant 62 Generic Version 62 Peginterferon alfa 2b 62 Premarket Approval 62 STELARA TM 62 EDQM 62 sublingual tablets 62 Rhucin R 62 SmPC 62 Mycamine 62 Yondelis ® 62 Metformin HCl 62 Neupro 62 JOULFERON 62 silodosin 61 PROVIGIL 61 PrandiMet 61 Telzir 61 SUMAVEL 61 Noxafil 61 levocetirizine 61 Evoltra R 61 desvenlafaxine 61 Nivestim 61 Febuxostat 61 Mylan Receives Approval 61 Neupro R 61 Accelerated Assessment 61 submitted Marketing Authorization 61 Teysuno 61 Kepivance 61 FOSRENOL 61 methylnaltrexone 61 Sodium Injection 61 Kuvan R 61 Keppra ® XR 61 solifenacin succinate 61 NOXAFIL 61 Veregen ® 61 Seasonal Influenza Vaccine 61 Renvela ® 61 orphan medicinal 61 Filgrastim 61 FDA Clearance 61 Sanvar R 61 BRILINTA 61 Clinical Trial Application 61 SUMAVEL DosePro 61 Somatuline R Depot 61 pediatric exclusivity 61 Dalbavancin 61 HFA MDI 61 Syndrome LEMS 61 Movectro 61 Keppra ® 61 Junovan 61 Fast Track designations 61 Biologics License Application 61 TYZEKA 61 MabCampath 61 Vimpat R 61 LUCASSIN 61 Tygacil 61 SAFLUTAN 61 Announces Tentative Approval 61 MAA submission 61 Recombinant Human 61 Submits Supplemental 61 Zegerid OTC 61 Zevtera ™ 61 Lovaza TM 61 REPLAGAL 60 Tredaptive 60 cSSTI 60 Azilect ® 60 Focetria 60 Abstral 60 Extended Release Capsules 60 Rhucin 60 Toctino R 60 Cefprozil 60 ZEFTERA ™ 60 Loramyc 60 CAMPATH R 60 Increlex ® 60 Clofarabine 60 Cimzia ® certolizumab pegol 60 rotigotine transdermal patch 60 Hexvix ® 60 Phase III Clinical Trial 60 Drug Submission 60 sevelamer carbonate 60 ceftobiprole 60 Swissmedic 60 Investigational Device Exemption 60 Receives Approvable Letter 60 Glybera R 60 Tetrabenazine 60 Tasigna nilotinib 60 Hycamtin 60 ARIXTRA R 60 Velaglucerase Alfa 60 CAELYX 60 Pafuramidine 60 Sycrest 60 Arzerra TM 60 Complete Response 60 SUTENT ® 60 Alfa Wassermann 60 balsalazide tablet 60 Lodotra 60 Multiferon R 60 Ranexa R 60 RAPTIVA 60 ATryn ® 60 Aviptadil 60 Wafer polifeprosan 60 Cladribine 60 Orphan Drug 60 CLIA waiver 60 Nabi HB Intravenous 60 Xenazine ® 60 human antithrombin 60 Argatroban 60 Zevtera TM 60 Betaseron ® 60 rasagiline tablets 60 StaphVAX R 60 rolling Biologics License 60 Tesamorelin 60 Zalbin 60 AERIUS 60 GTC recombinant human 60 ALVESCO R 60 ZALBIN 60 Tracleer r 60 Pliaglis 60 Investigational Compound 60 Drug Application 60 Marketing Authorisations 60 Entocort 60 RoACTEMRA 60 IRESSA 60 SCHWARZ PHARMA 60 Risperidone Oral Solution 60 mesylate 60 Australian Therapeutic Goods 60 Zenpep 60 Ustekinumab 60 Biological License Application 59 HuMax CD4 59 Toctino ® 59 SPRYCEL ® 59 HepaGam B 59 Vitaros 59 Barr ANDA 59 Gamunex C 59 taliglucerase alfa 59 Supplemental Biologics License Application 59 Keppra ® levetiracetam 59 Uracyst 59 Zirgan 59 Tacrolimus 59 miconazole MBT 59 Fortigel 59 Voraxaze 59 ELIQUIS 59 Firazyr ® 59 Irinotecan Hydrochloride Injection 59 Grants Orphan Drug 59 Xyzal R 59 Ilaris 59 VIVITROL ® 59 supplemental Biologics License Application 59 G#DT 59 Cimzia certolizumab pegol 59 Submits NDA 59 Amrubicin 59 OMAPRO ™ 59 Forsteo 59 Generic Version Of 59 methylnaltrexone bromide 59 Firdapse ™ amifampridine phosphate 59 oropharyngeal candidiasis 59 Efient 59 XIAFLEX ™ 59 Angiox R 59 Intravenous Hepatitis B 59 Aloxi R 59 Drug Eluting Stent System 59 Oral Solution 59 Orphan Drugs 59 Zebinix 59 Mepact 59 Files IND 59 Phase III Trial 59 Teva Provides Update 59 Extended Release 59 Nebido 59 Sebivo 59 buccal spray 59 Severe Sepsis 59 DC Bead 59 #mg Tablets [002] 59 Cimzia ® 59 Zevtera 59 Arixtra 59 Receives Fast Track 59 Somatuline Depot 59 Aphthasol R 59 REMICADE infliximab 59 Japanese Encephalitis Vaccine 59 cinacalcet HCl 59 CIP TRAMADOL ER 59 GRAS Status 59 Market Authorization Application 59 Extavia 59 Levoleucovorin 59 Basilea Toctino R 59 European Medicines Agency 59 Soliris TM eculizumab 59 UPLYSO 59 Cellegesic TM nitroglycerin ointment 59 MEPACT 59 Kuvan TM sapropterin 59 R bendamustine hydrochloride 59 IV acetaminophen 59 Rapinyl 59 Glucophage XR 59 Alitretinoin 59 Dabigatran etexilate 59 approvable letters 59 Citizen Petition 59 ReFacto 59 Dantrium R 59 ACOMPLIA R 59 vapreotide acetate 59 fluvoxamine maleate 59 Azathioprine 59 donepezil hydrochloride 59 commercialize oritavancin 59 Immune Globulin Human 59 Tigecycline 59 TRISENOX ® 59 BAL# [002] 59 Plasmin 59 ATryn R 59 DAYTRANA TM 59 Receives Complete Response 59 Pirfenidone 59 Joulferon 59 YONDELIS 59 Veregen R 59 FDA approvable letter 59 Keppra XR 59 Dupuytren Contracture 59 ONGLYZA TM 59 Fresenius Biotech 59 Rasilamlo 59 Xyzal 59 Tamsulosin 59 Aryplase 59 QVAR ® 58 Aclasta 58 HCl capsules 58 Advagraf R 58 TYGACIL 58 Cimzia R 58 Relistor 58 BARACLUDE R 58 Premarket Approval Application 58 PhotoCure 58 Testosterone Gel 58 Ceplene 58 capsule formulation 58 Aldara ® 58 ABILIFY R 58 RELISTOR 58 GMP Certificate 58 BYDUREON ™ 58 Topiramate Tablets 58 Pivotal Trial 58 Pennsaid R 58 Rapydan 58 Plicera 58 Inhalation Aerosol 58 alvimopan 58 Tibotec Therapeutics division 58 Ganciclovir 58 Product Monograph 58 Carbidopa Levodopa 58 supplemental biologics 58 NEBIDO 58 Vimpat ® lacosamide 58 Aloxi ® 58 Sumatriptan Succinate 58 Metvix 58 BioDelivery Sciences Announces 58 FlutiformTM 58 Betaferon R 58 Mirapexin 58 Zenapax 58 intravenous iclaprim 58 Xyzal ® 58 Levetiracetam Tablets 58 Synvisc One 58 terlipressin 58 PhosLo 58 OMNARIS 58 Zavesca r 58 Etanercept 58 Posaconazole 58 SUBOXONE 58 Polyphenon ® E 58 Patient Enrolment 58 octreotide acetate 58 Liberte TM 58 MEZAVANT R 58 Fortical R 58 pancreatic enzyme replacement 58 Fludara ® 58 Japanese Encephalitis vaccine 58 Dexilant 58 Rescula 58 Dyloject TM 58 Immunosuppressant 58 diclofenac sodium 58 Release Capsules 58 GI GVHD 58 Meets Primary Endpoint 58 Ramelteon 58 Gliadel R 58 RESOLOR 58 SABER ™ 58 Afluria 58 HepaSphere 58 NUEDEXTA ™ 58 Biologics License Application BLA 58 HuMax TAC 58 Velac 58 Entecavir 58 Somatuline Autogel 58 JAK Inhibitor 58 Replagal 58 Investigational Treatment 58 tramiprosate ALZHEMED TM 58 Campath ® 58 Generic Versions 58 Methylnaltrexone 58 Cipralex ® 58 BLA submission 58 Velcade bortezomib 58 HepaSphere Microspheres 58 Bazedoxifene 58 hoFH 58 Xolegel 58 Azilect R 58 Lubiprostone 58 human C1 inhibitor 58 Impavido R 58 Torisel 58 submitted Marketing Authorisation 58 Soliris eculizumab 58 Gonal f 58 atypical antipsychotic medication 58 received CE Conformite 58 1mg tablets 58 Granulocyte Colony Stimulating Factor 58 Santhera 58 Levofloxacin 58 AZILECT R 58 FIRMAGON R 58 Tekturna Rasilez 58 ELAPRASE 58 Targretin capsules 58 Clolar ® 58 Darunavir 58 WHO prequalification 58 Sonolith i move 58 amifampridine phosphate 58 Eloxatin ® 58 k Premarket Notification 58 Mycophenolate Mofetil 58 Ambrisentan 58 Hexvix 58 Metastatic Colorectal Cancer 58 sapropterin dihydrochloride 58 Initiate Clinical Trial 58 USFDA approval 58 PDUFA Prescription Drug 58 Clevudine 58 MONOVISC 58 Phase IIb Trial 58 Priority Review 58 ONSOLIS 58 AZILECT ® 58 Gaucher Disease 58 FDA Approval 58 Eligard ® 58 PMA Supplement 58 Rotarix R 58 CIMZIA r 58 Combidex 57 Ruconest ™ 57 Brovana 57 PROMACTA 57 Orally Disintegrating Tablets 57 CHMP Opinion 57 Resolor 57 Fortovase 57 Initiates Phase III 57 Falk Pharma 57 VPRIV 57 NerPharMa 57 daptomycin 57 Actimmune ® 57 CHMP 57 FOSAMAX PLUS D 57 Pre Filled Syringes 57 paliperidone palmitate 57 ZEGERID Chewable Tablets 57 Evoltra ® 57 Milestone Payments 57 FACTIVE R gemifloxacin 57 anagrelide hydrochloride 57 Eribulin 57 ORENCIA R 57 Human Medicinal Products 57 Cerepro ® 57 EGRIFTA TM 57 No Objection Letter 57 Sestamibi 57 SEASONALE R 57 #D#C# 57 Pazopanib 57 PLAVIX ® 57 BYETTA ® 57 SEASONALE 57 Pemetrexed 57 Octreotide 57 ezogabine 57 ORENCIA ® 57 NeoVisc 57 Alvesco 57 Dacogen injection 57 TRISENOX 57 Conditional Approval 57 CE IVD 57 Nycomed GmbH 57 COMFORT II 57 Pivotal Study 57 Viviant 57 Cinryze ™ 57 Vascular Wrap TM 57 Afinitor ® 57 Pegloticase 57 Uvidem 57 Adjuvant Treatment 57 Alogliptin 57 Application BLA 57 Valganciclovir 57 Soriatane 57 tafluprost 57 Administration TGA 57 Omacor ® 57 Nitoman 57 acyclovir Lauriad R 57 Sprycel dasatinib 57 Urocidin TM 57 Fondaparinux 57 PreHistin TM 57 Berinert 57 Hepatitis B Vaccine 57 Oral Calcitonin 57 efalizumab 57 FRDA 57 Levocetirizine 57 BENLYSTA 57 Metoprolol Succinate 57 BLA filing 57 Resubmission 57 ZEGERID Capsules 57 Imvamune 57 metformin HCl 57 gabapentin enacarbil 57 Fast Track designation 57 Thrombin topical Recombinant 57 Omnitrope 57 XIAFLEX ® 57 Complicated Skin 57 Ruconest TM 57 PREOS R 57 Fluconazole 57 Nexavar ® 57 TREDAPTIVE 57 Epo zeta 57 Aceon 57 Onsolis 57 BeneFIX 57 Amlodipine Besylate Tablets 57 Lilly Cymbalta 57 collagenase clostridium histolyticum 57 OLEPTRO 57 DYSPORT 57 MYLOTARG 57 XGEVA 57 etanercept Enbrel 57 herpetic keratitis 57 clofarabine 57 ONCASPAR 57 Loramyc ™ 57 Ondansetron 57 NEUPOGEN 57 Eucreas 57 GATTEX TM 57 RECOTHROM R 57 ciprofloxacin hydrochloride 57 Premarket Approval PMA 57 Vernalis plc 57 Qutenza TM 57 BioDelivery Sciences 57 Serdolect ® 57 Vimpat ® 57 trade name Normix 57 GRALISE 57 Market Approval PMA 57 BioAlliance 57 Silodosin 57 TORISEL 57 Bare Metal Stent 57 Rasilez HCT 57 Sensipar R 57 CERVARIX R 57 Humenza 57 IVD CE 57 Cetrorelix 57 Fodosine 57 Regulatory Approval 57 Centralised Procedure 57 R bivalirudin 57 highly purified pasteurized 57 miconazole Lauriad ® 57 Somatuline 57 Kit CD# positive 57 dihydrochloride 57 pancrelipase 57 Phase III Clinical Trials 57 Desvenlafaxine 57 Dynepo 57 Biologics Licensing 57 Genzyme Myozyme 57 application sNDA 57 Taro Receives 57 Decapeptyl ® 57 Veregen TM 57 Topical Gel 57 GABITRIL 57 Onbrez Breezhaler 57 Paragraph IV 57 Jevtana 57 PROTONIX 57 submitted Biologics License 57 Stedesa 57 Embosphere R 57 Calcium Acetate 57 sBLA 57 neovascular age 57 ENTEREG ® 57 Somatuline ® Autogel ® 57 DosePro TM 57 LHRH antagonist 57 Luveris 57 Kepivance ® 57 Kineret ® 57 prucalopride 57 UCB Keppra 57 Long Term Efficacy 57 Single Dose 57 Vernakalant 57 PRIALT 57 Cinacalcet HCl 57 GP Pharm 56 BfArM 56 Tekturna HCT 56 Neupro ® 56 Cayston 56 Moxifloxacin 56 Bosutinib 56 Glucomed 56 Nasacort 56 BEMA Fentanyl 56 Files Investigational 56 MOVIPREP R 56 Cethromycin 56 UCB Pharma SA 56 Clinical Efficacy 56 Degarelix 56 Kamada AAT 56 AMEVIVE 56 injectable formulations 56 VISICOL R 56 sublingual fentanyl 56 dual endothelin receptor antagonist 56 Manja Bouman CEO 56 Orphan medicinal 56 Cyanokit R 56 Personalized Immunotherapy 56 Maleate 56 VALSTAR 56 Auto Injector 56 nasal calcitonin product 56 ARCOXIA 56 oritavancin semi 56 Synerx Pharma 56 Pirespa 56 Lenalidomide 56 Initiates Enrollment 56 Flutiform TM 56 sNDAs 56 Photocure 56 Alemtuzumab 56 IND Application 56 intravitreal implant 56 cUTI 56 Perindopril 56 Notified Body 56 Mimpara R 56 ANVISA 56 Schizophrenia Drug 56 Sevelamer 56 Zavesca 56 Zingo TM 56 Antitrust Clearance 56 FDA Complete Response 56 Fanapt ™ 56 Multaq dronedarone 56 Removab 56 mg Tablets 56 NESINA 56 vinorelbine emulsion 56 Patient Enrollment 56 Actemra tocilizumab 56 RoActemra 56 Ceplene R 56 topical NSAID 56 interferon gamma 1b 56 Eligard R 56 Frova ® 56 Antidepressant Drug 56 miconazole Lauriad R 56 Evicel 56 Actimmune R 56 CELVAPAN H#N# 56 Pradaxa ® 56 Ventavis 56 Final Appraisal Determination 56 Xyntha 56 Irinotecan 56 Proquin XR 56 Fixed Dose Combination 56 SANVAR 56 NAVISTAR R 56 Nasal Spray 56 Extina 56 TYKERB 56 Lupin Pharmaceuticals Inc. 56 alefacept 56 Etravirine 56 TORISEL TM 56 YONDELIS R 56 ARIXTRA 56 sitagliptin phosphate 56 Medtronic CoreValve 56 cytokine immunomodulator 56 Morphine Sulfate 56 PecFent 56 AVASTIN 56 FACTIVE tablets 56 vancomycin hydrochloride 56 Tyverb 56 Alexion Soliris 56 Thelin tm 56 Prescribing Information 56 Focalin XR R 56 DepoDur 56 Omnaris 56 Tostran 56 Pixantrone 56 everolimus tablets 56 ZEVALIN ® 56 OsseoFix 56 transfusional iron overload 56 Arranon 56 Initiates Clinical 56 GEM #S 56 Investigational Agent 56 NOVARTIS 56 velaglucerase alfa 56 Receives CE Marking 56 antiretroviral medicinal 56 Begin Clinical Trials 56 Fingolimod 56 EVICEL 56 promote ceftobiprole 56 Synvisc ONE 56 Teflaro 56 Receives Tentative Approval 56 PrevOnco 56 Certolizumab pegol 56 Commercialization Agreement 56 balsalazide disodium 56 Cintredekin besudotox 56 Rifaximin 56 Nimotuzumab 56 Toremifene 56 Xerclear ™ 56 Fibrin Sealant Human 56 pioglitazone HCl 56 Proprietary Medicinal Products CPMP 56 XEOMIN 56 Multiferon 56 Captisol enabled 56 Antitumor 56 Tindamax 56 BEXXAR 56 Onalta 56 Vimpat 56 Release Tablets 56 acyclovir Lauriad ® 56 Exforge HCT 56 Orexo 56 NeoVisc ® 56 Avastin bevacizumab 56 Cefepime 56 Bepreve TM 56 azelastine 56 FOR FURTHER INFORMATION ABOUT 56 KALBITOR ® 56 Onco TCS 56 Strattera atomoxetine 56 Protopic 56 Emselex 56 sitagliptin metformin 56 memantine HCl 56 Pegintron 56 POSIDUR TM 56 Rheumatoid Arthritis Drug 56 Zorbtive TM 56 guanfacine extended release 56 TachoSil 56 BREAKYL 56 Gleevec imatinib mesylate 56 Extended Release Tablets 56 TOPAMAX R 56 Humira adalimumab 56 Receives Tentative FDA 56 Polymer Microspheres 56 MHLW 56 Divalproex Sodium 56 Omigard TM 56 Intravenous Formulation 56 WinRho R SDF 56 Vpriv 56 Traficet EN 56 Cloretazine ® 56 Aflunov 56 Ixempra 56 Betaferon ® 56 LEVAQUIN 56 LIALDA 56 Methylphenidate Transdermal System 56 Aztreonam Lysine 56 OLpur TM H2H 56 Serostim ® 56 Wellbutrin XL R 56 TRISENOX R 56 Augment Injectable 56 submitted supplemental Biologics 56 Drug Candidate 56 PROVIGIL R 56 No. #.# 56 Investigational Drug 56 Focalin XR ® 56 Docetaxel 56 granted Orphan Designation 56 PEG INTRON 56 Neulasta ® 56 Fenofibrate 56 Pixuvri 56 Valtropin 56 granulated mesalamine 56 Generic Lovenox 56 Telbivudine 56 Indomethacin 56 Jerini 56 Edurant 56 Approvable Letter 56 FDA Approvals 56 pantoprazole sodium 56 AMITIZA lubiprostone 56 Ceplene ® histamine dihydrochloride 56 Orencia abatacept 56 Uplyso 56 PROVENGE ® 56 Aplenzin 56 therefore therapeutically equivalent 56 DRAXIMAGE 56 casopitant 56 Prepandrix 56 Friedreich Ataxia FRDA 56 Optaflu 56 Aurograb 56 Ophthalmic Solution 56 ATRIPLA TM 56 Junovan TM 56 Vitrasert R 55 PROMUS TM 55 Orathecin 55 Tracleer ® 55 duloxetine hydrochloride 55 Bupropion HCl ER 55 prefilled pen 55 Iluvien ® 55 Inovelon 55 Delayed Release 55 PDE4 inhibitor 55 Genpharm 55 cinacalcet 55 Cefdinir 55 Tysabri natalizumab 55 Bicalutamide 55 ONTAK 55 Dermylex TM 55 PEGINTRON TM 55 Cloderm ® Cream 55 Cefixime 55 Vivaglobin 55 Periostat R 55 Zolpimist 55 hydrochloride tablets 55 ZEFTERA TM Zevtera TM 55 Topical Cream 55 Tarceva TM 55 TheraCIM 55 octagam ® 55 Belimumab 55 Prilosec omeprazole 55 Modrenal R 55 Lansoprazole 55 Biosimilar 55 Dostinex 55 Lamictal ODT 55 ATPace TM 55 vinflunine 55 ThromCat 55 mifamurtide 55 Receives Milestone Payment 55 hypereosinophilic syndrome 55 Bayer Onyx 55 Advanced Melanoma 55 Completes Patient Enrollment 55 Swedish Orphan Biovitrum 55 Vidaza azacitidine

Back to home page